Clinical trials are essential for advancing sarcoma treatment options and improving outcomes for patients with this form of cancer. Located near St. Petersburg, Florida, Moffitt Cancer Center in Tampa features cancer experts who advance research and knowledge of different types of cancer through our robust clinical trials program. Qualified patients who choose to participate in a clinical trial may benefit from the latest advances in sarcoma treatment before they’ve become widely available.
Sarcoma clinical trials at Moffitt could include study of:
- Antibody-based therapy to treat recurrent sarcomas
- New medications for chemotherapy-resistant sarcomas
- Less toxic treatments for pediatric patients
- Proton therapy as an alternative to radiation therapy
- Peripheral stem cell transplantation
- Screening methods that can help provide an early diagnosis
- Identifying risk factors and preventive options
At Moffitt, our researchers use clinical trials to improve treatment options for all current and future patients. Our dedication to advancing research of sarcoma and other cancers is why we’ve been designated as a Comprehensive Cancer Center from the National Cancer Institute, and we are the only such center based in Florida.
Patients who would like to receive sarcoma treatment or participate in one of our clinical trials are welcome to visit Moffitt. We provide all of our services under the same roof, making it convenient for our patients to receive the care and treatment they need without traveling to multiple locations.
To learn more about Moffitt’s current sarcoma clinical trials or to find out if you’re eligible to participate, call 813-745-6100 or 1-800-679-0775 (toll-free) or submit a clinical trials inquiry form online. No referral is necessary, and we accept patients from St. Petersburg and other parts of Florida.